FDA allows expanded use of Takeda's Velcade

06/23/2008 | Bloomberg

Takeda Pharmaceutical Co. Ltd. has obtained FDA clearance to market Velcade -- acquired through its $8.8 billion takeover of Millennium Pharmaceuticals in May -- as an initial treatment for patients with multiple myeloma. The additional approval is based on study results showing that Velcade helped 35% of people newly diagnosed with the blood cancer experience remission.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA